Atrial fibrillation (AF) may be treated by antiarrhythmic drugs (AAD) or catheter
ablation (ABL). The superiority of one strategy over the other has not been demonstrated.
An independent steering committee designed and supervised a randomized multicenter
(2 European, 2 North American) comparison of these treatments in pts with paroxysmal
AF resistant to one or more AADs.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Heart RhythmAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
Published online: August 02, 2006
Identification
Copyright
© 2006 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.